Antimicrobial Resistance in Food Animals and Human — a One Health Perspective

A special issue of Antibiotics (ISSN 2079-6382).

Deadline for manuscript submissions: 31 August 2024 | Viewed by 6966

Special Issue Editors


E-Mail Website
Guest Editor
Department of Food Testing and Research Laboratories of Thessaloniki, Hellenic Food Authority, 570 01 Thermi, Greece
Interests: antibiotics; foodborne pathogens; veterinary medicine; microbiology; antimicrobial resistance; antimicrobial susceptibility testing; food microbiology and safety

E-Mail Website
Guest Editor
Laboratory of Animal Food Products Hygiene and Veterinary Public Health, School of Veterinary Medicine, Aristotle University of Thessaloniki, 541 24 Thessaloniki, Greece
Interests: food microbiology and safety; foodborne pathogens; foodborne diseases; antimicrobial resistance; bacterial toxins; meat inspection; seafood safety
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Microbial resistance is considered a major health issue for humans and is considered one of the most important emerging pathogenic characteristics of zoonotic pathogens. The occurrence of resistant microorganisms in food animals has been well documented. In fact, specific antimicrobial resistance control programs in food animals have had an effect on the occurrence of resistant pathogens in humans. Therefore, an understanding of microbial resistance in the food animal–humans interface is deemed necessary for the prevention of this rather alarming phenomenon. As it involves the environment, animals, and humans, the study and prevention of antimicrobial resistance can only be carried out under the One Health umbrella.

This Special Issue aims to provide a platform for the publication of research concerning antimicrobial resistance in food animals, humans, and their interface, ideally using the One Health approach. Topics of interest include routes of transmission, the emergence of resistance in both food animals and humans, and resistance genes. Articles discussing new techniques for attenuating and controlling resistance in food animals or preventing its spread to humans are also welcome.

Dr. Panagiota Gousia
Dr. Vangelis Economou
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • antimicrobial resistance
  • multidrug resistance
  • food animals
  • One Health
  • zoonoses
  • resistance genes
  • food
  • foodborne pathogens
  • MRSA
  • VRE
  • carbapenemases
  • ESBL

Published Papers (3 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

14 pages, 2140 KiB  
Article
Prevalence, Genetic Homogeneity, and Antibiotic Resistance of Pathogenic Yersinia enterocolitica Strains Isolated from Slaughtered Pigs in Bulgaria
by Maya Angelovska, Maya Margaritova Zaharieva, Lyudmila L. Dimitrova, Tanya Dimova, Irina Gotova, Zoltan Urshev, Yana Ilieva, Mila Dobromirova Kaleva, Tanya Chan Kim, Sevda Naydenska, Zhechko Dimitrov and Hristo Najdenski
Antibiotics 2023, 12(4), 716; https://doi.org/10.3390/antibiotics12040716 - 06 Apr 2023
Cited by 3 | Viewed by 1654
Abstract
Yersiniosis is the third most commonly reported foodborne zoonosis in the European Union. Here, we evaluated the prevalence of pathogenic Yersinia enterocolitica among healthy pigs (as a major reservoir) in a slaughterhouse in Bulgaria. A total of 790 tonsils and feces from 601 [...] Read more.
Yersiniosis is the third most commonly reported foodborne zoonosis in the European Union. Here, we evaluated the prevalence of pathogenic Yersinia enterocolitica among healthy pigs (as a major reservoir) in a slaughterhouse in Bulgaria. A total of 790 tonsils and feces from 601 pigs were examined. Isolation and pathogenicity characterization was carried out by the ISO 10273:2003 protocol and Polymerase Chain Reaction (PCR), detecting the 16S rRNA gene, attachment and invasion locus (ail), Yersinia heat-stable enterotoxin (ystA), and Yersinia adhesion (yadA) genes. Genetic diversity was assessed by pulsed-field gel electrophoresis (PFGE), and antimicrobial resistance by the standard disk diffusion method. Of all the pigs tested, 6.7% were positive for Y. enterocolitica. All isolates belonged to Y. enterocolitica bioserotype 4/O:3. ail, and ystA genes were detected in all positive strains (n = 43), while the plasmid Yersinia virulence plasmid (pYV) was detected in 41. High homogeneity was observed among the strains, with all strains susceptible to ceftriaxone, amikacin and ciprofloxacin, and resistant to ampicillin. In conclusion, a low prevalence of Y. enterocolitica 4/O:3 was found in healthy pigs slaughtered in Bulgaria, not underestimating possible contamination of pork as a potential risk to consumer health. Full article
Show Figures

Figure 1

Review

Jump to: Research

16 pages, 962 KiB  
Review
Exploring Disease Management and Control through Pathogen Diagnostics and One Health Initiative: A Concise Review
by Riya Mukherjee, Jasmina Vidic, Sandrine Auger, Hsiao-Chuan Wen, Ramendra Pati Pandey and Chung-Ming Chang
Antibiotics 2024, 13(1), 17; https://doi.org/10.3390/antibiotics13010017 - 23 Dec 2023
Viewed by 2198
Abstract
The “One Health” initiative is a critical strategy that recognizes the interconnectedness between human, animal, and environmental health in the spread and containment of infectious pathogens. With the ease of global transportation, transboundary disease outbreaks pose a significant threat to food safety and [...] Read more.
The “One Health” initiative is a critical strategy that recognizes the interconnectedness between human, animal, and environmental health in the spread and containment of infectious pathogens. With the ease of global transportation, transboundary disease outbreaks pose a significant threat to food safety and security, endangering public health and having a negative economic impact. Traditional diagnostic techniques based on genotypic and phenotypic analyses are expensive, time-consuming, and cannot be translated into point-of-care tools, hindering effective disease management and control. However, with advancements in molecular methods, biosensors, and new generation sequencing, rapid and reliable diagnostics are now available. This review provides a comprehensive insight into emergent viral and bacterial pathogens and antimicrobial resistance, highlighting the importance of “One Health” in connecting detection and effective treatment. By emphasizing the symbiotic relationship between human and animal health, this paper underscores the critical role of “One Health” initiatives in preventing and controlling infectious diseases. Full article
Show Figures

Graphical abstract

14 pages, 648 KiB  
Review
Epidemiology of Staphylococcus aureus Non-Susceptible to Vancomycin in South Asia
by Mohammad Ejaz, Muhammad Ali Syed, Charlene R. Jackson, Mehmoona Sharif and Rani Faryal
Antibiotics 2023, 12(6), 972; https://doi.org/10.3390/antibiotics12060972 - 27 May 2023
Cited by 1 | Viewed by 2562
Abstract
Staphylococcus aureus is one of the ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species) pathogens among which multidrug resistance has emerged. Resistance to methicillin has resulted in clinicians using the antibiotic [...] Read more.
Staphylococcus aureus is one of the ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species) pathogens among which multidrug resistance has emerged. Resistance to methicillin has resulted in clinicians using the antibiotic of last resort, vancomycin, to treat infections caused by methicillin-resistant S. aureus (MRSA). However, excessive use and misuse of vancomycin are major causes of resistance among S. aureus strains. South Asia encompasses ~25% of the world’s population, and countries in South Asia are often characterized as low- and middle-income with poor healthcare infrastructure that may contribute to the emergence of antibiotic resistance. Here, we briefly highlight the mechanism of vancomycin resistance, its emergence in S. aureus, and the molecular epidemiology of non-susceptible S. aureus to vancomycin in the South Asian region. Full article
Show Figures

Figure 1

Back to TopTop